Construct: ORF ccsbBroadEn_02292
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF004833.1_s300c1, BRDN0000390666
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- BCL2L11 (10018)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_138621.5 | 100% | 100% | |
| 2 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204108.1 | 86% | 84.3% | (many diffs) |
| 3 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263556.3 | 86% | 80.3% | (many diffs) |
| 4 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263557.4 | 86% | 80.3% | (many diffs) |
| 5 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_138622.3 | 84.8% | 83.8% | (many diffs) |
| 6 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_006538.5 | 69.6% | 69.6% | 122_123ins180 |
| 7 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204109.1 | 69% | 67.1% | (many diffs) |
| 8 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263551.3 | 67.8% | 67.8% | 1_282del |
| 9 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_138624.3 | 67.5% | 66.6% | (many diffs) |
| 10 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_138626.3 | 66.8% | 66.1% | 395_399delGTATTinsC;401_402insCCATGAGGCAGGC;405_406ins180 |
| 11 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263550.4 | 59.8% | 55.8% | (many diffs) |
| 12 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263561.3 | 58% | 52.3% | (many diffs) |
| 13 | human | 10018 | BCL2L11 | BCL2 like 11 | XR_922828.3 | 54.9% | 1_342del;839_970del;1061_1062insAATGCAT | |
| 14 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204106.2 | 54.5% | 54.5% | 123_124ins270 |
| 15 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_138623.3 | 54.5% | 53.5% | (many diffs) |
| 16 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_011510461.3 | 52% | 42.3% | (many diffs) |
| 17 | human | 10018 | BCL2L11 | BCL2 like 11 | XR_922829.3 | 49.2% | 1_342del;839_1095del;1186_1187insAATGCAT | |
| 18 | human | 10018 | BCL2L11 | BCL2 like 11 | XR_001738579.2 | 48.4% | (many diffs) | |
| 19 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263553.3 | 47.2% | 47.2% | 1_282del;404_405ins180 |
| 20 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_207002.3 | 46.5% | 33.4% | (many diffs) |
| 21 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263554.3 | 45.4% | 44.8% | (many diffs) |
| 22 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204113.1 | 45.3% | 37.7% | (many diffs) |
| 23 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_017003102.1 | 44% | 38.3% | (many diffs) |
| 24 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204107.1 | 41.4% | 39.3% | (many diffs) |
| 25 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204110.2 | 40.5% | 38.8% | (many diffs) |
| 26 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263552.4 | 40.3% | 36.3% | (many diffs) |
| 27 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_207003.3 | 39.3% | 38.3% | (many diffs) |
| 28 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204112.2 | 38.8% | 36.8% | (many diffs) |
| 29 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_005263559.3 | 36.9% | 36.9% | 1_282del;405_406ins270 |
| 30 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_001204111.2 | 36.7% | 35.8% | (many diffs) |
| 31 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_011510464.3 | 31.9% | 23.6% | (many diffs) |
| 32 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_138625.4 | 31.1% | 27.2% | (many diffs) |
| 33 | human | 10018 | BCL2L11 | BCL2 like 11 | XM_017003101.2 | 25% | 24.3% | (many diffs) |
| 34 | human | 10018 | BCL2L11 | BCL2 like 11 | NM_138627.4 | 22.2% | 21.7% | 128T>A;130_131delTTinsCC;135_136ins459 |
| 35 | human | 10018 | BCL2L11 | BCL2 like 11 | XR_244801.3 | 11.2% | 1_342del;840_964del;1062_5277del | |
| 36 | human | 10018 | BCL2L11 | BCL2 like 11 | XR_001738580.2 | 7.8% | (many diffs) | |
| 37 | human | 10018 | BCL2L11 | BCL2 like 11 | XR_002958776.1 | 7.8% | (many diffs) | |
| 38 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | NM_207680.2 | 86.7% | 86.5% | (many diffs) |
| 39 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | XM_006498614.3 | 63.3% | 63.1% | (many diffs) |
| 40 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | NM_207681.2 | 60.5% | 60% | (many diffs) |
| 41 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | XM_006498615.3 | 50.1% | 47.4% | (many diffs) |
| 42 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | NM_009754.3 | 47.9% | 45% | (many diffs) |
| 43 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | XM_006498616.3 | 44.2% | 43.7% | (many diffs) |
| 44 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | NM_001291016.1 | 42.3% | 38.3% | (many diffs) |
| 45 | mouse | 12125 | Bcl2l11 | BCL2-like 11 (apoptosis fac... | XM_006498617.3 | 34.9% | 32.8% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 660
- ORF length:
- 594
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG 61 TTGGCATGGC AAAGCAACCT TCTGATGTAA GTTCTGAGTG TGACCGAGAA GGTAGACAAT 121 TGCAGCCTGC GGAGAGGCCT CCCCAGCTCA GACCTGGGGC CCCTACCTCC CTACAGACAG 181 AGCCACAAGG TAATCCTGAA GGCAATCACG GAGGTGAAGG GGACAGCTGC CCCCACGGCA 241 GCCCTCAGGG CCCGCTGGCC CCACCTGCCA GCCCTGGCCC TTTTGCTACC AGATCCCCGC 301 TTTTCATCTT TATGAGAAGA TCCTCCCTGC TGTCTCGATC CTCCAGTGGG TATTTCTCTT 361 TTGACACAGA CAGGAGCCCA GCACCCATGA GTTGTGACAA ATCAACACAA ACCCCAAGTC 421 CTCCTTGCCA GGCCTTCAAC CACTATCTCA GTGCAATGGC TTCCATGAGG CAGGCTGAAC 481 CTGCAGATAT GCGCCCAGAG ATATGGATCG CCCAAGAGTT GCGGCGTATT GGAGACGAGT 541 TTAACGCTTA CTATGCAAGG AGGGTATTTT TGAATAATTA CCAAGCAGCC GAAGACCACC 601 CACGAATGGT TATCTTACGA CTGTTACGTT ACATTGTCCG CCTGGTGTGG AGAATGCATT 661 GCCCAACTTT CTTGTACAAA GTtggcatta taagaaagca ttgcttatca atttgttgca 721 acgaac